Cargando…
Daeshiho-tang Attenuates Atherosclerosis by Regulating Cholesterol Metabolism and Inducing M2 Macrophage Polarization
Dyslipidemia, the commonest cause of cardiovascular disease, leads to lipid deposits on the arterial wall, thereby aggravating atherosclerosis. DSHT (Daeshiho-tang) has long been used as an anti-dyslipidemia agent in oriental medicine. However, the anti-atherosclerotic effects of DSHT have not been...
Autores principales: | Song, Min-Young, Cho, Haneul, Lee, Sora, Lee, Kyung Hye, Kim, Weon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879110/ https://www.ncbi.nlm.nih.gov/pubmed/35207485 http://dx.doi.org/10.3390/life12020197 |
Ejemplares similares
-
LDL cholesterol-lowering effect of Daeshiho-tang in patients with dyslipidemia: A pilot randomized, double-blind, placebo-controlled trial
por: Noh, Ji-Won, et al.
Publicado: (2023) -
Daeshiho-tang attenuates inflammatory response and oxidative stress in LPS-stimulated macrophages by regulating TLR4/MyD88, NF-κB, MAPK, and Nrf2/HO-1 pathways
por: Oh, Yong Jin, et al.
Publicado: (2023) -
Macrophage polarization and metabolism in atherosclerosis
por: Hou, Pengbo, et al.
Publicado: (2023) -
Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?
por: Yvan-Charvet, Laurent, et al.
Publicado: (2020) -
Substance P enhances the local activation of NK(1)R-expressing c-kit(+) cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart
por: Jeong, Yun-Mi, et al.
Publicado: (2020)